• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 626857 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1419259360 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1419259360 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

United Therapeutics Bullish Moving Average Crossover Alert (UTHR)

Published on Tue, 11/19/2013 - 12:16
By Mallory Stone

Today, shares of United Therapeutics (NASDAQ:UTHR) have crossed bullishly above their 10-day moving average of $91.48 on a volume of 152K shares. This may provide swing traders with an opportunity for a long position, as such a crossover often suggests higher prices in the near term.

United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. United's products are currently in Phase III clinical trials.

United Therapeutics (NASDAQ:UTHR) defies analysts with a current price ($91.60) 15.4% above its average consensus price target of $77.46. The stock should find initial support at its 50-day moving average (MA) of $83.55 and further support at its 200-day MA of $69.94.

In the past 52 weeks, shares of United Therapeutics have traded between a low of $36.55 and a high of $94.22 and are now at $91.60, which is 151% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.8% while the 50-day MA has advanced 1.3%.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

SanDisk Fulfills the Promise: Up 1.2% Si...

One week ago SanDisk (NASDAQ:SNDK) was upgraded from Hold to Buy at Summit Research. T ...

Magellan Midstream Partners Fulfills the...

A week ago, Argus Research upgraded Magellan Midstream Partners from Hold to Buy. The ...

William Blair's Rating Change Only Had S...

William Blair downgraded Markel (NYSE:MKL) from Outperform to Market Perform a week ago ...

William Blair's Rating Change Only Had S...

William Blair downgraded CNA Financial (NYSE:CNA) from Outperform to Market Perform a w ...

Argo Group Gives Way to the Analysts: Do...

Argo Group was downgraded from Outperform to Market Perform by William Blair one week a ...

TriQuint Semiconductor In Retrospect: Sh...

DA Davidson downgraded TriQuint Semiconductor (NASDAQ:TQNT) from Buy to Neutral a week ...

RF Micro Devices Up 3.0% Since DA Davids...

A week ago, DA Davidson downgraded RF Micro Devices from Buy to Neutral. The shares cl ...

Chicago Bridge & Iron Up 5.5% Since Stif...

A week ago, Stifel downgraded Chicago Bridge & Iron from Buy to Hold. Chicago Bridge & ...